![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
1 Receptor Agonists in Rat Hippocampal Neurons
Hôpital Charcot, Plaisir, France (F.P.M.); Institut National de la Santé et de la Recherche Médicale Unité 488, Kremlin-Bicêtre, France (F.P.M., M.P.M.-S., J.L.); and Institut National de la Santé et de la Recherche Médicale Unité 442, B
timent 443, Campus d'Orsay, Université Paris Sud, Orsay, France (L.C.)
Intracellular calcium concentration ([Ca2+]i) plays a major role in neuronal excitability, especially that triggered by the N-methyl-D-aspartate (NMDA)-sensitive glutamatergic receptor. We have previously shown that
1 receptor agonists potentiate NMDA receptor-mediated neuronal activity in the hippocampus and recruit Ca2+-dependent second messenger cascades (e.g., protein kinase C; PKC) in brainstem motor structures. The present study therefore assessed whether the potentiating action of
1 agonists on the NMDA response observed in the hippocampus involves the regulation of [Ca2+]i and PKC. For this purpose, [Ca2+]i changes after NMDA receptor activation were monitored in primary cultures of embryonic rat hippocampal pyramidal neurons using microspectrofluorometry of the Ca2+-sensitive indicator Fura-2/acetoxymethyl ester in the presence of
1 agonists and PKC inhibitors. We show that successive activations of the
1 receptor by 1-min pulses of (+)-benzomorphans or (+)-N-cyclopropylmethyl-N-methyl-1,4-diphenyl-1-ethyl-but-3-en-1-ylamine hydrochloride (JO-1784) concommitantly with glutamate time dependently potentiated before inconstantly inhibiting the NMDA receptor-mediated increase of [Ca2+]i, whereas 1,3-di-o-tolyl-guanidine, a mixed
1/
2 agonist, did not significantly modify the glutamate response. Both potentiation and inhibition were prevented by the selective
1 antagonist N,N-dipropyl-2-[4-methoxy-3-(211phenylethoxy) phenyl]-ethylamine monohydrochloride (NE-100). Furthermore, only (+)-benzomorphans could induce [Ca2+]i influx by themselves after a brief pulse of glutamate. A pretreatment with the conventional PKC inhibitor 12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo [2,3-a] pyrrolo [3,4-c] carbazole (Gö-6976) prevented the potentiating effect of (+)-benzomorphans on the glutamate response. Our results provide further support for a general mechanism for the intracellular
1 receptor to regulate Ca2+-dependent signal transduction and protein phosphorylation.
Address correspondence to: Dr. F. P. Monnet, Institut National de la Santé et de la Recherche Médicale Unité 488, 80 rue du Général Leclerc, F-94276 Kremlin-Bicêtre cedex, France. E-mail: monnet{at}kb.inserm.fr
This article has been cited by other articles:
![]() |
C. Kibaly, L. Meyer, C. Patte-Mensah, and A. G. Mensah-Nyagan Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cord FASEB J, January 1, 2008; 22(1): 93 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Katnik, W. R. Guerrero, K. R. Pennypacker, Y. Herrera, and J. Cuevas Sigma-1 Receptor Activation Prevents Intracellular Calcium Dysregulation in Cortical Neurons during in Vitro Ischemia J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1355 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Meunier, J. Ieni, and T. Maurice Antiamnesic and Neuroprotective Effects of Donepezil against Learning Impairments Induced in Mice by Exposure to Carbon Monoxide Gas J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1307 - 1319. [Abstract] [Full Text] [PDF] |
||||